HEATHER ANDERSON: Open Payments
NPI 1679931083 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 33 payments from 14 companies in 2025. Trend: 2023 $295 · 2024 $622 · 2025 $734
Food & beverage: $635Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $185 |
| AstraZeneca Pharmaceuticals LP | 7 | $162 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Lundbeck LLC | 3 | $67 |
| ABBVIE INC. | 3 | $61 |
| ABIOMED | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: BREZTRI, REXULTI, Veozah, VRAYLAR, CAPLYTA, VYEPTI, VOQUEZNA, Kerendia.
Industry payments across MS — which companies pay providers there.
